vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Distribution Solutions Group, Inc. (DSGR). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $518.0M, roughly 1.8× Distribution Solutions Group, Inc.). Distribution Solutions Group, Inc. runs the higher net margin — 1.2% vs 0.7%, a 0.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 10.7%). Distribution Solutions Group, Inc. produced more free cash flow last quarter ($32.9M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 13.1%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
ASTH vs DSGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $518.0M |
| Net Profit | $6.6M | $6.5M |
| Gross Margin | — | 32.9% |
| Operating Margin | 1.9% | 4.6% |
| Net Margin | 0.7% | 1.2% |
| Revenue YoY | 42.9% | 10.7% |
| Net Profit YoY | 184.4% | -70.6% |
| EPS (diluted) | $0.12 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $518.0M | ||
| Q2 25 | $654.8M | $502.4M | ||
| Q1 25 | $620.4M | $478.0M | ||
| Q4 24 | $665.2M | $480.5M | ||
| Q3 24 | $478.7M | $468.0M | ||
| Q2 24 | $486.3M | $439.5M | ||
| Q1 24 | $404.4M | $416.1M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $6.5M | ||
| Q2 25 | $9.4M | $5.0M | ||
| Q1 25 | $6.7M | $3.3M | ||
| Q4 24 | $-7.8M | $-25.9M | ||
| Q3 24 | $16.1M | $21.9M | ||
| Q2 24 | $19.2M | $1.9M | ||
| Q1 24 | $14.8M | $-5.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 33.9% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | — | 33.9% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 34.5% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | 4.6% | ||
| Q2 25 | 3.1% | 5.3% | ||
| Q1 25 | 3.3% | 4.2% | ||
| Q4 24 | 0.1% | 4.2% | ||
| Q3 24 | 5.9% | 4.0% | ||
| Q2 24 | 6.2% | 3.2% | ||
| Q1 24 | 7.5% | 0.7% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | 1.2% | ||
| Q2 25 | 1.4% | 1.0% | ||
| Q1 25 | 1.1% | 0.7% | ||
| Q4 24 | -1.2% | -5.4% | ||
| Q3 24 | 3.4% | 4.7% | ||
| Q2 24 | 3.9% | 0.4% | ||
| Q1 24 | 3.7% | -1.3% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.14 | ||
| Q2 25 | $0.19 | $0.11 | ||
| Q1 25 | $0.14 | $0.07 | ||
| Q4 24 | $-0.14 | $-0.55 | ||
| Q3 24 | $0.33 | $0.46 | ||
| Q2 24 | $0.40 | $0.04 | ||
| Q1 24 | $0.31 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $69.2M |
| Total DebtLower is stronger | — | $665.5M |
| Stockholders' EquityBook value | $779.3M | $653.9M |
| Total Assets | $2.2B | $1.8B |
| Debt / EquityLower = less leverage | — | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $69.2M | ||
| Q2 25 | $342.1M | $47.4M | ||
| Q1 25 | $260.9M | $65.4M | ||
| Q4 24 | $290.8M | $66.5M | ||
| Q3 24 | $350.3M | $61.3M | ||
| Q2 24 | $327.7M | $46.8M | ||
| Q1 24 | $337.3M | $73.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $665.5M | ||
| Q2 25 | — | $675.0M | ||
| Q1 25 | — | $712.4M | ||
| Q4 24 | — | $693.9M | ||
| Q3 24 | — | $704.1M | ||
| Q2 24 | — | $573.7M | ||
| Q1 24 | — | $535.7M |
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $653.9M | ||
| Q2 25 | $765.5M | $649.4M | ||
| Q1 25 | $745.4M | $636.7M | ||
| Q4 24 | $712.7M | $640.5M | ||
| Q3 24 | $704.6M | $680.8M | ||
| Q2 24 | $678.9M | $653.3M | ||
| Q1 24 | $653.5M | $654.7M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $1.8B | ||
| Q2 25 | $1.4B | $1.8B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.8B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.2B | $1.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.02× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.88× | ||
| Q1 24 | — | 0.82× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $38.4M |
| Free Cash FlowOCF − Capex | $-6.0M | $32.9M |
| FCF MarginFCF / Revenue | -0.6% | 6.3% |
| Capex IntensityCapex / Revenue | 0.3% | 1.1% |
| Cash ConversionOCF / Net Profit | -0.44× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $92.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $38.4M | ||
| Q2 25 | $90.9M | $33.3M | ||
| Q1 25 | $16.6M | $-4.8M | ||
| Q4 24 | $-10.9M | $45.7M | ||
| Q3 24 | $34.0M | $-17.3M | ||
| Q2 24 | $23.2M | $21.4M | ||
| Q1 24 | $6.0M | $6.6M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $32.9M | ||
| Q2 25 | $89.5M | $28.7M | ||
| Q1 25 | $13.6M | $-10.4M | ||
| Q4 24 | $-13.5M | $41.1M | ||
| Q3 24 | $31.7M | $-20.5M | ||
| Q2 24 | $20.4M | $18.0M | ||
| Q1 24 | $5.6M | $4.2M |
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 6.3% | ||
| Q2 25 | 13.7% | 5.7% | ||
| Q1 25 | 2.2% | -2.2% | ||
| Q4 24 | -2.0% | 8.6% | ||
| Q3 24 | 6.6% | -4.4% | ||
| Q2 24 | 4.2% | 4.1% | ||
| Q1 24 | 1.4% | 1.0% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 1.1% | ||
| Q2 25 | 0.2% | 0.9% | ||
| Q1 25 | 0.5% | 1.2% | ||
| Q4 24 | 0.4% | 1.0% | ||
| Q3 24 | 0.5% | 0.7% | ||
| Q2 24 | 0.6% | 0.8% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 5.95× | ||
| Q2 25 | 9.65× | 6.66× | ||
| Q1 25 | 2.48× | -1.46× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | -0.79× | ||
| Q2 24 | 1.21× | 11.28× | ||
| Q1 24 | 0.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
